Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL)

NCT00972842 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Peripheral T-Cell Non-Hodgkin's Lymphoma

Interventions

DRUG: Vorinostat, Lenalidomide

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]
[object Object]